Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

8.55
Delayed Data
As of Jun 29
 -0.14 / -1.61%
Today’s Change
6.61
Today|||52-Week Range
16.87
-30.20%
Year-to-Date

Today’s Trading

Previous close8.69
Today’s open8.59
Day’s range-- - --
Volume2,501,701
Average volume (3 months)3,305,342
Market cap$1.0B
Dividend yield--
Data as of 06/29/2015

Growth & Valuation

Earnings growth (last year)-11.11%
Earnings growth (this year)+7.31%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.27

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc-0.37-4.98%
ARNAArena Pharmaceutical...-0.09-2.05%
HRTXHeron Therapeutics I...-0.80-2.66%
PDLIPDL BioPharma Inc-0.15-2.30%
Data as of 06/29/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$69.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers